American Heart Association

The latest news from the AHA Scientific Sessions, with physician perspective, researcher interviews and clinician insight on cardiovascular prevention and more.

Meeting News

No benefit on myocardial injury with colchicine before PCI

November 20, 2019
PHILADELPHIA — Acute preprocedural administration of colchicine did not reduce PCI-related myocardial injury or MACE compared with placebo, but…
Meeting News

Meth cessation may reverse drug-induced HF

November 20, 2019
PHILADELPHIA — Among methamphetamine users with drug-induced HF, stopping use conferred improved HF symptoms, according to data presented at…
Meeting News

Race influences decision making for advanced HF therapies

November 19, 2019
PHILADELPHIA — Health care professionals’ decision-making processes may contribute to racial disparities in HF treatment. Researchers…
Meeting News

Vitamin D, fish oil fail to reduce first HF hospitalization risk

November 19, 2019
PHILADELPHIA — Interventions with vitamin D or omega-3 failed to reduce rates of first heart failure hospitalization in a large cohort of…
Meeting NewsPerspective

ORION-9: Inclisiran safely lowers LDL up to 50% in familial hypercholesterolemia

November 18, 2019
PHILADELPHIA — Patients with heterozygous familial hypercholesterolemia who were treated with inclisiran had reductions in LDL at 510 days and…
Meeting News

Lower LDL target beneficial after stroke

November 18, 2019
PHILADELPHIA — Among patients with signs of atherosclerosis following stroke or transient ischemic attack, those who achieved a target LDL…
Meeting News

Apabetalone fails to benefit MACE, but ‘cautious optimism’ remains

November 18, 2019
PHILADELPHIA — Among adults with recent ACS and type 2 diabetes, treatment with the BET inhibitor apabetalone for 26 months failed to show…
Meeting News

FUEL: Udenafil improves certain exercise performance after Fontan palliation in adolescents

November 18, 2019
PHILADELPHIA — Udenafil in adolescents after Fontan surgery did not significantly improve oxygen consumption at peak exercise, although it did…
Meeting News

Icosapent ethyl shows benefit on several plaque characteristics at 9 months: EVAPORATE

November 18, 2019
PHILADELPHIA — Interim data using coronary CT angiography demonstrated benefits of icosapent ethyl as an adjunct to statin therapy on several…
Meeting NewsPerspective

Novel RNA interference agents improve lipid profiles in healthy volunteers

November 18, 2019
PHILADELPHIA — Two novel RNA interference agents, one targeting apolipoprotein C-III and one targeting angiopoietin-like protein 3, improved…